Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin: A nationwide cohort study

Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, Anders Gorst-Rasmussen, Flemming Skjøth, Mary Rosenzweig, Deirdre Lane, Gregory Y H Lip

Research output: Contribution to journalJournal articleResearchpeer-review

61 Citations (Scopus)

Abstract

Dabigatran may provide less protection against myocardial infarction than vitamin K antagonists (VKAs) in patients with atrial fibrillation. This may be particularly evident among 'switchers' to dabigatran from VKA, as a result of discontinuation effects.
Original languageEnglish
JournalAmerican Journal of Medicine
Volume127
Issue number4
Pages (from-to)329-336
Number of pages8
ISSN0002-9343
DOIs
Publication statusPublished - 2014

Fingerprint

Dive into the research topics of 'Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin: A nationwide cohort study'. Together they form a unique fingerprint.

Cite this